FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-8283com.
(The FASEB Journal. 2008;22:561-568.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.07-8283comv1
fj.07-8283comv2
22/2/561    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDunn, J. E.
Right arrow Articles by Hotchkiss, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDunn, J. E.
Right arrow Articles by Hotchkiss, R. S.
(The FASEB Journal. 2008;22:561-568.)
© 2008 FASEB

Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis

Jonathan E. McDunn*,{dagger},1, Jared T. Muenzer{ddagger}, Latif Rachdi§, Katherine C. Chang*, Chris G. Davis*, W. Michael Dunne||, David Piwnica-Worms,#, Ernesto Bernal-Mizrachi§ and Richard S. Hotchkiss*,{dagger},§

Department of
* Anesthesiology,

{dagger} Department of Surgery,

{ddagger} Department of Pediatrics,

§ Department of Medicine,

|| Department of Molecular Microbiology,

Department of Molecular Biology and Pharmacology, and

# Molecular Imaging Center, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri, USA

1Correspondence: Campus Box 8054, 660 South Euclid Ave., Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, 63110, USA. E-mail: mcdunnj{at}wustl.edu

Lymphocyte apoptosis is a hallmark of sepsis and contributes to disease mortality. In other acute injuries, such as myocardial and cerebral ischemia/reperfusion, apoptosis plays a significant role in disease-associated morbidity and mortality. We previously showed that constitutive activation of the potent antiapoptotic Akt/protein kinase B signaling pathway in lymphocytes both reduces sepsis-induced lymphocyte apoptosis and confers a significant survival advantage compared to wild-type littermates. Here, we demonstrate a therapeutic approach to acutely augment Akt activity in a wild-type animal. A cell-permeable peptide conjugated to the Akt-binding domain of the endogenous Akt coactivator, Tcl-1, prolongs Akt activity, activates extracellular regulated kinase (ERK) signaling and protects lymphocytes from numerous apoptotic stimuli both in vitro and in vivo. Molecular approaches to activate the antiapoptotic Akt and ERK signaling pathways may provide a novel tool to study these signaling pathways, as well as a new antiapoptotic strategy for the treatment of sepsis and other acute injuries. McDunn, J. E., Muenzer, J. T., Rachdi, L., Chang, K. C., Davis, C. G., Dunne, W. M., Piwnica-Worms, D., Mizrachi, E.-B., Hotchkiss, R. S. Peptide-mediated activation of Akt and ERK signaling prevents lymphocyte apoptosis.


Key Words:







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.